drugset / Trial / NCT04405388

Summary

The impact of daily spermidine application on arterial blood pressure and other secondary parameters will be evaluated in a double-blind single center 46 patients cross-over study.

Timeline

Start
2020-02-25
Primary completion
2024-11-15
Completion
2024-11-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Spermidine Other / unclassified 4 mg Oral

Indications